PARP Inhibitors

Exploiting Cancer Synthetic Lethality in Cancer---Lessons Learnt from PARP Inhibitors
PARP inhibitors now have proven utility in the treatment of homologous recombination (HR) defective cancers. These drugs, and the …
Cite DOI Book chapter